Literature DB >> 22547003

Activation of muscarinic receptors increases the activity of the granule neurones of the rat dorsal cochlear nucleus--a calcium imaging study.

Áron Kőszeghy1, János Vincze, Zoltán Rusznák, Yuhong Fu, George Paxinos, László Csernoch, Géza Szücs.   

Abstract

Acetylcholine modulates the function of the cochlear nucleus via several pathways. In this study, the effects of cholinergic stimulation were studied on the cytoplasmic Ca(2+) concentration of granule neurones of the rat dorsal cochlear nucleus (DCN). Ca(2+) transients were recorded in Oregon-Green-BAPTA 1-loaded brain slices using a calcium imaging technique. For the detection, identification and characterisation of the Ca(2+) transients, a wavelet analysis-based method was developed. Granule cells were identified on the basis of their size and localisation. The action potential-coupled character of the Ca(2+) transients of the granule cells was established by recording fluorescence changes and electrical activity simultaneously. Application of the cholinergic agonist carbamyl-choline (CCh) significantly increased the frequency of the Ca(2+) transients (from 0.37 to 6.31 min(-1), corresponding to a 17.1-fold increase; n = 89). This effect was antagonised by atropine, whereas CCh could still evoke an 8.3-fold increase of the frequency of the Ca(2+) transients when hexamethonium was present. Using immunolabelling, the expression of both type 1 and type 3 muscarinic receptors (M1 and M3 receptors, respectively) was demonstrated in the granule cells. Application of 1,1-dimethyl-4-diphenylacetoxypiperidinium iodide (an M3-specific antagonist) prevented the onset of the CCh effect, whereas an M1-specific antagonist (pirenzepine) was less effective. We conclude that cholinergic stimulation increases the activity of granule cells, mainly by acting on their M3 receptors. The modulation of the firing activity of the granule cells, in turn, may modify the firing of projection neurones and may adjust signal processing in the entire DCN.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22547003     DOI: 10.1007/s00424-012-1103-1

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  43 in total

1.  Bidirectional synaptic plasticity in the cerebellum-like mammalian dorsal cochlear nucleus.

Authors:  Kiyohiro Fujino; Donata Oertel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-16       Impact factor: 11.205

Review 2.  Pathways modulating neural KCNQ/M (Kv7) potassium channels.

Authors:  Patrick Delmas; David A Brown
Journal:  Nat Rev Neurosci       Date:  2005-11       Impact factor: 34.870

3.  Cytoplasmic Ca(2+) concentration changes evoked by cholinergic stimulation in primary astrocyte cultures prepared from the rat cochlear nucleus.

Authors:  Pál Pap; Aron Koszeghy; Géza Szucs; Zoltán Rusznák
Journal:  Hear Res       Date:  2009-06-02       Impact factor: 3.208

4.  Membrane currents influencing action potential latency in granule neurons of the rat cochlear nucleus.

Authors:  Z Rusznák; I D Forsythe; H M Brew; P R Stanfield
Journal:  Eur J Neurosci       Date:  1997-11       Impact factor: 3.386

5.  Immunolocalization of muscarinic acetylcholine subtype 2 receptors in rat cochlear nucleus.

Authors:  W Yao; D A Godfrey; A I Levey
Journal:  J Comp Neurol       Date:  1996-09-09       Impact factor: 3.215

6.  Ca2+ buffering and action potential-evoked Ca2+ signaling in dendrites of pyramidal neurons.

Authors:  F Helmchen; K Imoto; B Sakmann
Journal:  Biophys J       Date:  1996-02       Impact factor: 4.033

Review 7.  Muscarinic acetylcholine receptors: signal transduction through multiple effectors.

Authors:  C C Felder
Journal:  FASEB J       Date:  1995-05       Impact factor: 5.191

8.  Mossy fiber projections from the cuneate nucleus to the cochlear nucleus in the rat.

Authors:  D D Wright; D K Ryugo
Journal:  J Comp Neurol       Date:  1996-01-29       Impact factor: 3.215

9.  Cholinergic modulation of spontaneous activity in rat dorsal cochlear nucleus.

Authors:  K Chen; H J Waller; D A Godfrey
Journal:  Hear Res       Date:  1994-06-15       Impact factor: 3.208

10.  Immunohistochemistry of muscarinic acetylcholine receptors in rat cochlear nucleus.

Authors:  W Yao; D A Godfrey
Journal:  Hear Res       Date:  1995-09       Impact factor: 3.208

View more
  6 in total

1.  Amino acid and acetylcholine chemistry in mountain beaver cochlear nucleus and comparisons to pocket gopher, other rodents, and cat.

Authors:  Donald A Godfrey; Nikki L Mikesell; Timothy G Godfrey; James A Kaltenbach
Journal:  Hear Res       Date:  2019-11-10       Impact factor: 3.208

2.  Cholinergic modulation of large-conductance calcium-activated potassium channels regulates synaptic strength and spine calcium in cartwheel cells of the dorsal cochlear nucleus.

Authors:  Shan He; Ya-Xian Wang; Ronald S Petralia; Stephan D Brenowitz
Journal:  J Neurosci       Date:  2014-04-09       Impact factor: 6.167

3.  Quantitative distribution of choline acetyltransferase activity in rat trapezoid body.

Authors:  Lauren A Linker; Lissette Carlson; Donald A Godfrey; Judy A Parli; C David Ross
Journal:  Hear Res       Date:  2018-08-25       Impact factor: 3.208

4.  Suppression of noise-induced hyperactivity in the dorsal cochlear nucleus following application of the cholinergic agonist, carbachol.

Authors:  N F Manzoor; G Chen; J A Kaltenbach
Journal:  Brain Res       Date:  2013-05-27       Impact factor: 3.252

5.  Myosin phosphatase and RhoA-activated kinase modulate neurotransmitter release by regulating SNAP-25 of SNARE complex.

Authors:  Dániel Horváth; István Tamás; Adrienn Sipos; Zsuzsanna Darula; Bálint Bécsi; Dénes Nagy; Judit Iván; Ferenc Erdődi; Beáta Lontay
Journal:  PLoS One       Date:  2017-05-09       Impact factor: 3.240

6.  Slow Cholinergic Modulation of Spike Probability in Ultra-Fast Time-Coding Sensory Neurons.

Authors:  David Goyer; Stefanie Kurth; Charlène Gillet; Christian Keine; Rudolf Rübsamen; Thomas Kuenzel
Journal:  eNeuro       Date:  2016-09-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.